{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T01:18:08Z","timestamp":1766711888500},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1093\/brain\/122.3.441","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:28:32Z","timestamp":1027722512000},"page":"441-448","source":"Crossref","is-referenced-by-count":29,"title":["Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence?"],"prefix":"10.1093","volume":"122","author":[{"given":"David","family":"Chadwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,3]]},"reference":[{"key":"key\n\t\t\t\t20170624064708_ANNEGERS-ETAL-1979","doi-asserted-by":"crossref","unstructured":"Annegers JF, Hauser WA, Elverback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia1979; 20: 729\u201337.","DOI":"10.1111\/j.1528-1157.1979.tb04857.x"},{"key":"key\n\t\t\t\t20170624064708_BERG-AND-SHINNAR-1994","doi-asserted-by":"crossref","unstructured":"Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs: a meta-analysis [see comments]. Neurology1994; 44: 601\u20138. Comment in: ACP J Club 1994; 121 Suppl 2: 53.","DOI":"10.1212\/WNL.44.4.601"},{"key":"key\n\t\t\t\t20170624064708_BRODIE-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy [published erratum appears in Lancet 1995; 345: 662] [see comments]. Lancet1995; 345: 476\u20139. Comment in: Lancet 1995; 345: 1300\u20132.","DOI":"10.1016\/S0140-6736(95)90581-2"},{"key":"key\n\t\t\t\t20170624064708_BUCHTHAL-ETAL-1968","doi-asserted-by":"crossref","unstructured":"Buchthal F, Svensmark O, Simonsen H. Relation of EEG and seizures to phenobarbital in serum. Arch Neurol1968; 19: 567\u201372.","DOI":"10.1001\/archneur.1968.00480060037004"},{"key":"key\n\t\t\t\t20170624064708_CAMFIELD-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Camfield P, Camfield C, Dooley J, Smith E, Garner B. A randomized study of carbamazepine versus no medication after a first unprovoked seizure in childhood [see comments]. Neurology1989; 39: 851\u20132. Comment in: Neurology 1989; 39: 1645\u20136.","DOI":"10.1212\/WNL.39.6.851"},{"key":"key\n\t\t\t\t20170624064708_CHADWICK-1997","unstructured":"Chadwick D. Rational drug therapy of epilepsy. In: Porter RJ, Chadwick D, editors. The epilepsies 2. Boston: Butterworth-Heinemann; 1997. p. 247\u201366."},{"key":"key\n\t\t\t\t20170624064708_CHADWICK-ETAL-1996","unstructured":"Chadwick DW, Roi L, Kennedy KM. Vigabatrin (Sabril) as a first-line monotherapy in newly diagnosed epilepsy: a double-blind comparison with carbamazepine [abstract]. Epilepsia1996; 37 Suppl 4: 6."},{"key":"key\n\t\t\t\t20170624064708_CHADWICK-ETAL-1997","unstructured":"Chadwick D, Anhut H, Murray G, Greiner M, Alexander J. Gabapentin monotherapy in patients with newly diagnosed epilepsy: results of a double-blind fixed-dose study comparing three dosages of gabapentin and open-label carbamazepine [abstract]. Epilepsia1997; 38 Suppl 3: 34."},{"key":"key\n\t\t\t\t20170624064708_CHANDRA-1992","doi-asserted-by":"crossref","unstructured":"Chandra B. First seizure in adults: to treat or not to treat? [published erratum appears in Clin Neurol Neurosurg 1992; 94: 89] Clinical Neurol Neurosurg1992; 94 Suppl: S613.","DOI":"10.1016\/0303-8467(92)90024-W"},{"key":"key\n\t\t\t\t20170624064708_COCKERELL-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Cockerell OC, Johnson AL, Sander JW, et al. Remission of Epilepsy: Results from the National General Practice Study of Epilepsy. Lancet1995; 346: 140\u20134.","DOI":"10.1016\/S0140-6736(95)91208-8"},{"key":"key\n\t\t\t\t20170624064708_COMMISSION-ON-ANTIEPILEPTIC-DRUGS-OF-THE-INTERNATIONAL-LEAGUE-AGAINST-EPILEPSY-1989","doi-asserted-by":"crossref","unstructured":"Commission on Antiepileptic Drugs of the International League against Epilepsy. Guidelines for clinical evaluation of antiepileptic drugs. Epilepsia1989; 30: 400\u20138.","DOI":"10.1111\/j.1528-1157.1989.tb05317.x"},{"key":"key\n\t\t\t\t20170624064708_DUNCAN-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Duncan JS, Shorvon SD, Trimble MR. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy. Epilepsia1990; 31: 324\u201333.","DOI":"10.1111\/j.1528-1157.1990.tb05383.x"},{"key":"key\n\t\t\t\t20170624064708_FIRST-SEIZURE-TRIAL-GROUP-1993","doi-asserted-by":"crossref","unstructured":"First Seizure Trial Group (FIR.S.T. Group). Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic\u2013clonic seizure [see comments]. Neurology1993; 43: 478\u201383. Comment in: Neurology 1994; 44: 781\u20132.","DOI":"10.1212\/WNL.43.3_Part_1.478"},{"key":"key\n\t\t\t\t20170624064708_HELLER-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Heller AJ, Chesterman P, Elwes RD, Crawford P, Chadwick D, Johnson AL, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry1995; 58: 44\u201350.","DOI":"10.1136\/jnnp.58.1.44"},{"key":"key\n\t\t\t\t20170624064708_JONES-ETAL-1996","unstructured":"Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods [see comments] [published erratum appears in BMJ 1996; 313: 550]. BMJ1996; 313: 36\u20139. Comment in: BMJ 1996; 313: 3\u20134."},{"key":"key\n\t\t\t\t20170624064708_KALVIAINEN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"K\u00e4lvi\u00e4inen R, \u00c4iki\u00e4 M, Saukkonen AM, Mervaala E, Riekkinen PJ Sr. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study [see comments]. Arch Neurol1995; 52: 989\u201396. Comment in: Arch Neurol 1995; 53: 477\u20138.","DOI":"10.1001\/archneur.1995.00540340081016"},{"key":"key\n\t\t\t\t20170624064708_LEBER-1989","doi-asserted-by":"crossref","unstructured":"Leber PD. Hazards of inference: the active control investigation. Epilepsia1989; 30 Suppl 1: S57\u201363.","DOI":"10.1111\/j.1528-1157.1989.tb05816.x"},{"key":"key\n\t\t\t\t20170624064708_MARSON-AND-CHADWICK-1996","doi-asserted-by":"crossref","unstructured":"Marson AG, Chadwick DW. How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches. Epilepsia1996; 37: 377\u201380.","DOI":"10.1111\/j.1528-1157.1996.tb00575.x"},{"key":"key\n\t\t\t\t20170624064708_MATTSON-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic\u2013clonic seizures. N Engl J Med1985; 313: 145\u201351.","DOI":"10.1056\/NEJM198507183130303"},{"key":"key\n\t\t\t\t20170624064708_MATTSON-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic\u2013clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group [see comments]. N Engl J Med1992; 327: 765\u201371. Comment in: N Engl J Med 1992; 328: 207\u20139.","DOI":"10.1056\/NEJM199209103271104"},{"key":"key\n\t\t\t\t20170624064708_MCNAMARA-1986","unstructured":"McNamara JO. Kindling model of epilepsy. [Review]. Adv Neurol1986; 44: 303\u201318."},{"key":"key\n\t\t\t\t20170624064708_MEDICAL-RESEARCH-COUNCIL-ANTIEPILEPTIC-DRUG-WITHDRAWAL-STUDY-GROUP-1993","doi-asserted-by":"crossref","unstructured":"Medical Research Council Antiepileptic Drug Withdrawal Study Group. Prognostic index for recurrence of seizures after remission of epilepsy. BMJ1993; 306: 1374\u20138.","DOI":"10.1136\/bmj.306.6889.1374"},{"key":"key\n\t\t\t\t20170624064708_MEDICAL-RESEARCH-COUNCIL-ANTIEPILEPTIC-DRUG-WITHDRAWAL-STUDY-GROUP-1991","doi-asserted-by":"crossref","unstructured":"Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomized study of antiepileptic drug withdrawal in patients in remission. Lancet1991; 337: 1175\u201380.","DOI":"10.1016\/0140-6736(91)92856-W"},{"key":"key\n\t\t\t\t20170624064708_RICHENS-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Richens A, Davidson DL, Cartlidge NE, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. J Neurol Neurosurg Psychiatry1994; 57: 682\u20137.","DOI":"10.1136\/jnnp.57.6.682"},{"key":"key\n\t\t\t\t20170624064708_ROTHMAN-AND-MICHELS-1994","doi-asserted-by":"crossref","unstructured":"Rothman KJ, Michels KB. The continuing unethical use of placebo controls [see comments]. N Engl J Med1994; 331: 394\u20138. Comment in: N Engl J Med 1995; 332: 60\u20132.","DOI":"10.1056\/NEJM199408113310611"},{"key":"key\n\t\t\t\t20170624064708_SNEAD-AND-HOSEY-1985","doi-asserted-by":"crossref","unstructured":"Snead OC 3rd, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med1985; 313: 916\u201321.","DOI":"10.1056\/NEJM198510103131503"},{"key":"key\n\t\t\t\t20170624064708_STEINER-AND-YUEN-1994","unstructured":"Steiner TJ, Yuen AWC. Comparison of lamotrigine and phenytoin monotherapy in newly diagnosed epilepsy [abstract]. Epilepsia1994; 35 Suppl 8: 31."},{"key":"key\n\t\t\t\t20170624064708_TEMPLE-1982","doi-asserted-by":"crossref","unstructured":"Temple R. Government viewpoint on clinical trials. Drug Information J1982; 1: 10\u20137.","DOI":"10.1177\/009286158201600102"},{"key":"key\n\t\t\t\t20170624064708_VERITY-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Verity CM, Hosking G, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol1995; 37: 97\u2013108.","DOI":"10.1111\/j.1469-8749.1995.tb11978.x"},{"key":"key\n\t\t\t\t20170624064708_WADA-1977","doi-asserted-by":"crossref","unstructured":"Wada JA. Pharmacological prophylaxis in the kindling model of epilepsy. [Review]. Arch Neurol1977; 34: 389\u201395.","DOI":"10.1001\/archneur.1977.00500190023003"},{"key":"key\n\t\t\t\t20170624064708_WHITE-1997","unstructured":"White HS. Mechanisms of antiepileptic drugs. In: Porter RJ, Chadwick D, editors. The epilepsies 2. Boston: Butterworth-Heinemann; 1997. p. 1\u201330."}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/122\/3\/441\/17873126\/1220441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:28:20Z","timestamp":1583310500000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/122.3.441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,3]]},"published-print":{"date-parts":[[1999,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/122.3.441","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}